State Street Corp United Therapeutics Corp Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, State Street Corp holds 1,935,119 shares of UTHR stock, worth $532 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,935,119

Previous 1,947,177 0.62%

Holding current value

$532 Million

Previous $428 Million 3.82%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $2.54 Million - $3.01 Million	-12,058 Reduced 0.62%	1,935,119 $445 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $14.6 Million - $17.4 Million	67,907 Added 3.61%	1,947,177 $428 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $743,911 - $871,818	3,512 Added 0.19%	1,879,270 $424 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $16.5 Million - $18.8 Million	80,656 Added 4.49%	1,875,758 $414 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $52.3 Million - $67.9 Million	245,747 Added 15.86%	1,795,102 $402 Million

Q4 2022 Feb 14, 2023	SELL	$205.95 - $280.43 $9.61 Million - $13.1 Million	-46,662 Reduced 2.92%	1,549,355 $431 Million
Q3 2022 Nov 15, 2022	BUY	$203.3 - $244.17 $5.05 Million - $6.06 Million	24,822 Added 1.58%	1,596,017 $334 Million
Q2 2022 Aug 15, 2022	SELL	$174.81 - $241.14 $9.67 Million - $13.3 Million	-55,296 Reduced 3.4%	1,571,195 $370 Million
Q1 2022 May 16, 2022	BUY	$166.16 - $213.96 $18.1 Million - $23.4 Million	109,226 Added 7.2%	1,626,491 $292 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $10 Million - $11.8 Million	54,462 Added 3.72%	1,517,265 $328 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $854,694 - $1.02 Million	4,752 Added 0.33%	1,462,803 $270 Million
Q2 2021 Aug 16, 2021	BUY	$170.47 - $211.93 $13.3 Million - $16.5 Million	77,964 Added 5.65%	1,458,051 $262 Million
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $24.5 Million - $27.9 Million	-159,395 Reduced 10.35%	1,380,087 $231 Million
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $3.11 Million - $4.63 Million	30,491 Added 2.02%	1,539,482 $234 Million
Q3 2020 Nov 10, 2020	SELL	$99.9 - $121.13 $464,734 - $563,496	-4,652 Reduced 0.31%	1,508,991 $152 Million
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $37.4 Million - $50.7 Million	-402,889 Reduced 21.02%	1,513,643 $183 Million
Q1 2020 May 11, 2020	BUY	$79.39 - $115.35 $152 Million - $221 Million	1,916,532 New	1,916,532 $182 Million

Others Institutions Holding UTHR

# of Institutions

562

Shares Held

43.1M

Call Options Held

501K

Put Options Held

529K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $12.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp United Therapeutics Corp Transaction History